An ocular drug delivery system (ODDS) is a dosage form, vehicle, or system intended to instill, administer, or deliver drug/medicine to the eye against any ailment or disorder involving or affecting vision. It ranges from simple sterile eye drop for the ocular surface to complex implants for intraocular tissue. Ocular drug formulations are primarily liquid forms, such as solutions, suspensions, and emulsions for treating anterior eye segment diseases.
Get More Details with Sample PDF Copy @ https://www.theinsightpartners.com/sample/TIPRE00004206/
Ocular Drug Delivery Market: Competitive Landscape and Key Developments: AbbVie Inc Bausch Health Companies Inc Taiwan Liposome Company Ltd Ocular Therapeutix Inc GRAYBUG VISION INC Alimera Sciences Inc Envisia Therapeutics Novartis AG EYEGATE PHARMACEUTICALS
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: [email protected]
Phone: +1-646-491-9876